Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrien Rochand

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Drugs|February 21, 2020
Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future PerspectivesJuliette Palle, Adrien Rochand, Simon Pernot, et al.
Bulletin Du Cancer|June 27, 2022
Future treatment options in metastatic clear cell renal cell carcinomaAudrey Simonaggio, Marie Auvray-Kuentz, Adrien Rochand, et al.
Bulletin Du Cancer|March 11, 2023
[Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies]Zoé Guillaume, Yves Allory, Edouard Auclin, et al.
European Urology Oncology|April 22, 2026
Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 TrialsCharles Vauchier, Constance Thibault, Maud Velev, et al.
The Laryngoscope|May 31, 2022
Long-Term Outcomes in Head and Neck Paragangliomas Managed with Intensity-Modulated RadiotherapyGuillaume Rougier, Adrien Rochand, Rémi Bourdais, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 30, 2025
Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective studyElisabeth Ashton, Nicolas Delanoy, Rym El Gharib, et al.
JCO Precision Oncology|August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene AlterationsMihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancerEdouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2023
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRAS<sup>G12C</sup>-Mutant Lung CancerAli Chour, Julie Denis, Céline Mascaux, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drugs|February 21, 2020
Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future PerspectivesJuliette Palle, Adrien Rochand, Simon Pernot, et al.
Bulletin Du Cancer|June 27, 2022
Future treatment options in metastatic clear cell renal cell carcinomaAudrey Simonaggio, Marie Auvray-Kuentz, Adrien Rochand, et al.
Bulletin Du Cancer|March 11, 2023
[Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies]Zoé Guillaume, Yves Allory, Edouard Auclin, et al.
European Urology Oncology|April 22, 2026
Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 TrialsCharles Vauchier, Constance Thibault, Maud Velev, et al.
The Laryngoscope|May 31, 2022
Long-Term Outcomes in Head and Neck Paragangliomas Managed with Intensity-Modulated RadiotherapyGuillaume Rougier, Adrien Rochand, Rémi Bourdais, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 30, 2025
Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective studyElisabeth Ashton, Nicolas Delanoy, Rym El Gharib, et al.
JCO Precision Oncology|August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene AlterationsMihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancerEdouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2023
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRAS<sup>G12C</sup>-Mutant Lung CancerAli Chour, Julie Denis, Céline Mascaux, et al.
Pageof 1